Related Experiment Video
Updated: Feb 12, 2026

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
Doxycycline Prophylaxis for Bacterial Sexually Transmitted Infections: Promises and Perils
Martin Siguier1, Jean-Michel Molina1
1Department of Infectious Diseases , Saint-Louis Hospital, APHP, and University of Paris Diderot , Paris 75000 , France.
Abstract:
Despite their high global incidence, sexually transmitted infections (STIs) remain a neglected area of research. Increased rates of STIs have been reported in particular among men who have sex with men (MSM) probably because of the advances in the treatment and prophylaxis of human immunodeficiency virus (HIV) infection with a decrease in condom use. A recent report among MSM showed that the use of postexposure prophylaxis with doxycycline could dramatically reduce the incidence of chlamydia and syphilis but not of gonorrhea. The long-term consequences of this strategy are yet unknown, especially the risk of selection and dissemination of syphilis and chlamydia strains with doxycycline resistance, which has not been reported yet.
Insights
Sexually transmitted infections (STIs) are rising in men who have sex with men (MSM). Doxycycline postexposure prophylaxis reduced chlamydia and syphilis but not gonorrhea, with unknown long-term resistance risks.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Sexually transmitted infections (STIs) represent a significant global health burden.
- Increased STI incidence is observed in men who have sex with men (MSM), potentially linked to reduced condom use following advances in HIV prevention.
- Current research explores novel strategies to mitigate STI transmission in high-risk populations.
Purpose of the Study:
- To evaluate the efficacy of doxycycline postexposure prophylaxis (PEP) in reducing STI incidence among MSM.
- To investigate the impact of doxycycline PEP on specific STIs, including chlamydia, syphilis, and gonorrhea.
- To identify potential long-term consequences and risks associated with doxycycline PEP, such as antimicrobial resistance.
Main Methods:
- A recent report analyzed STI incidence data among MSM utilizing doxycycline PEP.
- The study compared the rates of chlamydia, syphilis, and gonorrhea before and after the implementation of doxycycline PEP.
- Observational analysis focused on the effectiveness and potential adverse outcomes of the prophylactic strategy.
Main Results:
- Doxycycline PEP significantly reduced the incidence of chlamydia and syphilis in the studied MSM population.
- No significant reduction in gonorrhea incidence was observed with doxycycline PEP.
- The long-term effects and the potential for doxycycline resistance in syphilis and chlamydia strains remain undetermined.
Conclusions:
- Doxycycline PEP shows promise in curbing chlamydia and syphilis rates among MSM.
- Gonorrhea remains a challenge for doxycycline PEP, necessitating alternative or adjunctive prevention strategies.
- Further research is crucial to understand the long-term implications of doxycycline PEP, particularly regarding the emergence of antimicrobial resistance.
Related Concept Videos
Sexually Transmitted Infections
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the...
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Bacterial Signaling
Bacterial RNA Polymerase
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...

